Science and Enterprise

Tag: NIH

  • Grant Awarded for Nicotine Vaccine

    Selecta Biosciences Inc. in Watertown, Massachusetts received a grant for $3 million from the National Institute on Drug Abuse, a part of National Institutes of Health (NIH), to advance development of an enhanced vaccine to help treat nicotine addiction and aid in smoking cessation and relapse prevention. The grant will fund a candidate from Selecta’s…

  • NIH Seeking Small Business Proposals for HazMat Training

    The National Institute of Environmental Health Sciences (NIEHS) wants ideas from small businesses for using advanced technology to train HazMat workers and emergency responders to better protect themselves and their communities from hazardous materials. NIEHS, part of National Institutes of Health, has issued a funding announcement seeking applications under the Small Business Innovation Research program.…

  • NIH Extends Comment Period on New Conflict Regulations

    National Institutes of Health (NIH) extended the comment period on proposed conflict-of-interest rules for researchers to 19 August 2010. The extended period on the new rules, officially known as “Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought and Responsible Prospective Contractors,” seeks comments on specific topics that arose since…

  • Biotech Company Wins NIH Biodefense Grants

    MacroGenics Inc, a biotechnology company in Rockville, Maryland, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million. MacroGenics develops therapeutics to treat autoimmune disorders, cancer and infectious diseases. The company says the NIH grants will advance its Dual-Affinity Re-Targeting (DART) platform, as…